• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
×

Target

Host

Species Reactivity

Species Reactivity

Conjugate

Conjugate

SERINC1 Polyclonal antibody

SERINC1 Polyclonal Antibody for WB, IHC, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, IF/ICC, ELISA

Conjugate

Unconjugated

Cat no : 20265-1-AP

Synonyms

KIAA1253, SERINC1, serine incorporator 1, TDE1L, TDE2, TMS 2

Validation Data Gallery

Filter:
  • Western Blot (WB) analysis of HeLa cells using SERINC1 Polyclonal antibody (20265-1-AP)

    WB analysis of HeLa using 20265-1-AP

    HeLa cells were subjected to SDS PAGE followed by western blot with 20265-1-AP (SERINC1 antibody) at dilution of 1:100 incubated at room temperature for 1.5 hours.

  • Western Blot (WB) analysis of HepG2 cells using SERINC1 Polyclonal antibody (20265-1-AP)

    WB analysis of HepG2 using 20265-1-AP

    HepG2 cells were subjected to SDS PAGE followed by western blot with 20265-1-AP (SERINC1 antibody) at dilution of 1:100 incubated at room temperature for 1.5 hours.

  • Western Blot (WB) analysis of L02 cells using SERINC1 Polyclonal antibody (20265-1-AP)

    WB analysis of L02 using 20265-1-AP

    L02 cells were subjected to SDS PAGE followed by western blot with 20265-1-AP (SERINC1 antibody) at dilution of 1:100 incubated at room temperature for 1.5 hours.

  • Immunohistochemistry (IHC) staining of human liver cancer tissue using SERINC1 Polyclonal antibody (20265-1-AP)

    IHC staining of human liver cancer using 20265-1-AP

    Immunohistochemical analysis of paraffin-embedded human liver cancer using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human liver cancer tissue using SERINC1 Polyclonal antibody (20265-1-AP)

    IHC staining of human liver cancer using 20265-1-AP

    Immunohistochemical analysis of paraffin-embedded human liver cancer using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 (under 40x lens).

  • Immunohistochemistry (IHC) staining of human cervical cancer tissue using SERINC1 Polyclonal antibody (20265-1-AP)

    IHC staining of human cervical cancer using 20265-1-AP

    Immunohistochemical analysis of paraffin-embedded human cervical cancer using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human cervical cancer tissue using SERINC1 Polyclonal antibody (20265-1-AP)

    IHC staining of human cervical cancer using 20265-1-AP

    Immunohistochemical analysis of paraffin-embedded human cervical cancer using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 (under 40x lens).

  • Immunohistochemistry (IHC) staining of human liver cancer tissue using SERINC1 Polyclonal antibody (20265-1-AP)

    IHC staining of human liver cancer using 20265-1-AP

    Immunohistochemical analysis of paraffin-embedded human liver cancer using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human liver cancer tissue using SERINC1 Polyclonal antibody (20265-1-AP)

    IHC staining of human liver cancer using 20265-1-AP

    Immunohistochemical analysis of paraffin-embedded human liver cancer using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 (under 40x lens).

  • Immunofluorescence (IF) / fluorescent staining of HepG2 cells using SERINC1 Polyclonal antibody (20265-1-AP)

    IF Staining of HepG2 using 20265-1-AP

    Immunofluorescent analysis of (-20℃ Ethanol) fixed HepG2 cells using 20265-1-AP (SERINC1 antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG(H+L).

☆大好評トライアルサイズ ¥20,000～！ >>> 一次抗体特別価格キャンペーン開催中！

Tested Applications

Positive WB detected inHeLa cells, HepG2 cells, L02 cells
Positive IHC detected inhuman liver cancer tissue, human cervical cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:200-1:1000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

20265-1-AP targets SERINC1 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Peptide 相同性解析による交差性が予測される生物種
Full Name serine incorporator 1
Calculated molecular weight 51 kDa
Observed molecular weight 65 kDa
GenBank accession numberNM_020755
Gene symbol SERINC1
Gene ID (NCBI) 57515
RRIDAB_10693613
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

SERINC1, also named as KIAA1253, TDE1L and TDE2, belongs to the TDE1 family. SERINC1 enhances the incorporation of serine into phosphatidylserine and sphingolipids. The antibody is specific to SERINC1.

Protocols

Product Specific Protocols
WB protocol for SERINC1 antibody 20265-1-APDownload protocol
IHC protocol for SERINC1 antibody 20265-1-APDownload protocol
IF protocol for SERINC1 antibody 20265-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols